Healthcare & Life Sciences

InCarda Therapeutics Inc

aliveseries-c-plus
series-c-plus
Stage
1
Investors

About

InCarda Therapeutics develops drug therapies designed to restore normal heart rhythm in patients with atrial fibrillation, focusing on treatments usable both in hospital settings and at home.

Explore InCarda Therapeutics Inc's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.